PillSeek

Reviewed by PillSeek Editorial Team · Last updated

Buprenorphine HCl and naloxone HCl

Buprenorphine hydrochloride 8 mg;naloxone hydrochloride dihydrate 2 mg;

OrangeRoundDEA Schedule Ciii

About This Medication

This medication is an Orange Round 11 mm, Tablet with imprint "AN;415". It contains Buprenorphine hydrochloride 8 mg;naloxone hydrochloride dihydrate 2 mg; of Buprenorphine hydrochloride[buprenorphine];naloxone hydrochloride dihydrate[naloxone];. It is manufactured by AvKARE, Inc.. For details please contact your physician.

Basic Information

Imprint
AN;415
Color
Orange
Shape
Round
Size
11 mm

Drug Information

Strength
Buprenorphine hydrochloride 8 mg;naloxone hydrochloride dihydrate 2 mg;
Dosage Form
Tablet
RxCUI
351267
DEA Schedule
Schedule Ciii

Ingredients

Active Ingredients
Buprenorphine hydrochloride[buprenorphine];naloxone hydrochloride dihydrate[naloxone];
Inactive Ingredients
Acesulfame potassium;anhydrous citric acid;fd&c yellow no. 6;lactose monohydrate;magnesium stearate;mannitol;povidone;sodium citrate;starch, corn;

Additional Information

Manufacturer
AvKARE, Inc.
Status (Rx/OTC)
Rx

⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.

Orange Round Buprenorphine HCl and naloxone HCl Buprenorphine hydrochloride 8 mg;naloxone hydrochloride dihydrate 2 mg; Pill With Imprint AN;415 | PillSeek